baclofen has been researched along with Paralysis, Legs in 53 studies
Excerpt | Relevance | Reference |
---|---|---|
"To report insidious development of autonomic dysreflexia and hydronephrosis due to dyssynergic voiding following discontinuation of intrathecal baclofen therapy." | 7.72 | Delayed complications of discontinuation of intrathecal baclofen therapy: resurgence of dyssynergic voiding, which triggered off autonomic dysreflexia and hydronephrosis. ( Hughes, PL; Mansour, P; Oo, T; Singh, G; Soni, BM; Vaidyanathan, S, 2004) |
"A comparative clinical trial with oral and intravenous baclofen (Lioresal) was performed in a homogeneous group of 70 male patients, hospitalized with traumatic paraplegia." | 7.65 | Clinical and laboratory assessment of the efficacy of baclofen (Lioresal) on urethral sphincter spasticity in patients with traumatic paraplegia. ( Hachen, HJ; Krucker, V, 1977) |
"In this case, treatment of severe spasticity and nociceptive pain was required while avoiding potentially lethal side effects of sudden baclofen withdrawal." | 5.62 | Baclofen bridging, weaning protocol and pain management of a person with T6 paraplegia who required removal of intrathecal baclofen pump due to wound infection. ( Agha, H; Davis, C; Roth, J, 2021) |
"Ischemic paraplegia was induced in Sprague-Dawley rats by transient aortic occlusion (10 min) in combination with systemic hypotension (40 mm Hg)." | 5.33 | Measurement of peripheral muscle resistance in rats with chronic ischemia-induced paraplegia or morphine-induced rigidity using a semi-automated computer-controlled muscle resistance meter. ( Hefferan, MP; Kakinohana, O; Marsala, J; Marsala, M; Nakamura, S; Tomori, Z, 2005) |
" He developed acute kidney injury at hospital secondary to vancomycin use, and mental status declined." | 5.05 | Encephalopathy of Unknown Origin in a Baclofen Patient: Case Report and Review of the Literature. ( Abraham, M; Behmer Hansen, R; Gold, J; Lad, M; Mammis, A; Zhao, K, 2020) |
"37-year-old with T9 motor complete paraplegia with ITB presented in baclofen withdrawal." | 4.31 | Interaction between a smartphone and intrathecal baclofen pump case report. ( Filipetto, F; Trbovich, M; Walden, J, 2023) |
"We report here the case of a 53-year-old woman with spastic paraplegia treated with intrathecal baclofen." | 3.80 | Isotopic scintigraphy combined with computed tomography: a useful method for investigating inefficiency of intrathecal baclofen. ( Couturier, O; Dinomais, M; Ferrapie, AL; Frémondière, F; Lacœuille, F; Menei, P; Richard, I; Saoût, V, 2014) |
"A 66-year-old man affected by familial spastic paraplegia since he was 22 developed drug tolerance to intrathecal baclofen after 16 years of treatment A stable dosage of 850 microg/day, achieved after the first two years, appeared to be progressively inadeguate to relief his spasticity." | 3.76 | A case of very long-term appearing drug tolerance to intrathecal baclofen. ( Broggi, G; Dones, I, 2010) |
"We present a case of a 38-year-old male with complete T9 spastic paraplegia for 15 years, treated with intrathecal baclofen for 11 years." | 3.72 | Subdural catheter migration may lead to baclofen pump dysfunction. ( Cahana, A; Pasquier, Y; Schnider, A, 2003) |
"A 30-year-old female patient is described with incomplete paraplegia below T6 on the left side and below T8 on the right side, ASIA B, caused by trauma occurring 12 years previously, in whom an intrathecal system had been implanted for baclofen infusion 10 years ago." | 3.72 | Efficacy of intrathecal morphine in the treatment of baclofen tolerance in a patient on intrathecal baclofen therapy (ITB). ( Gregori, P; Guevara, D; Portell, E; Vallés, M; Vidal, J, 2004) |
"To report insidious development of autonomic dysreflexia and hydronephrosis due to dyssynergic voiding following discontinuation of intrathecal baclofen therapy." | 3.72 | Delayed complications of discontinuation of intrathecal baclofen therapy: resurgence of dyssynergic voiding, which triggered off autonomic dysreflexia and hydronephrosis. ( Hughes, PL; Mansour, P; Oo, T; Singh, G; Soni, BM; Vaidyanathan, S, 2004) |
"To determine if continuous intrathecal baclofen infusion (CIBI) would provide continuous relief of spasticity in patients with spasticity of cerebral origin, especially children with cerebral palsy." | 3.68 | Continuous intrathecal baclofen infusion for spasticity of cerebral origin. ( Albright, AL; Barron, WB; Fasick, MP; Janosky, J; Polinko, P, 1993) |
"A lactating woman with spastic paraplegia was given 94 mumol (20 mg) of baclofen orally to study the transport of the drug into breast milk." | 3.66 | Concentrations of baclofen in serum and breast milk from a lactating woman. ( Eriksson, G; Swahn, CG, 1981) |
"This report summarizes experience with baclofen (Lioresal) in the management of spasticity and muscle spasms in 113 patients treated for up to six years." | 3.65 | Bacloffen (Lioresal) in the long-term management of spasticity. ( Jones, RF; Lance, JW, 1976) |
"A comparative clinical trial with oral and intravenous baclofen (Lioresal) was performed in a homogeneous group of 70 male patients, hospitalized with traumatic paraplegia." | 3.65 | Clinical and laboratory assessment of the efficacy of baclofen (Lioresal) on urethral sphincter spasticity in patients with traumatic paraplegia. ( Hachen, HJ; Krucker, V, 1977) |
"Baclofen was not effective at sustaining plasma IGF-1 concentrations in the physiological range in men with chronic SCI." | 2.78 | Low-dose baclofen therapy raised plasma insulin-like growth factor-1 concentrations, but not into the normal range in a predictable and sustained manner in men with chronic spinal cord injury. ( Bauman, WA; Cirnigliaro, CM; Kirshblum, SC; La Fountaine, MF; Spungen, AM, 2013) |
"We concur with the concept that neuroleptic malignant syndrome represents a spectrum of disorders, and add it to the list of possible sequelae after abrupt withdrawal of baclofen." | 2.41 | Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen. ( Gainsborough, N; Turner, MR, 2001) |
"In this case, treatment of severe spasticity and nociceptive pain was required while avoiding potentially lethal side effects of sudden baclofen withdrawal." | 1.62 | Baclofen bridging, weaning protocol and pain management of a person with T6 paraplegia who required removal of intrathecal baclofen pump due to wound infection. ( Agha, H; Davis, C; Roth, J, 2021) |
"We report a case of Spastic paraplegia 8 (SPG8) with a novel mutation of KIAA0196 gene." | 1.48 | A novel KIAA0196 mutation in a Chinese patient with spastic paraplegia 8: A case report. ( Chen, Z; Li, S; Ma, L; Qin, W; Shi, Y; Zhang, J, 2018) |
"Baclofen is a gamma-aminobutyric acid agonist used primarily as a muscle relaxant to treat spasticity in children and adults." | 1.39 | Use of baclofen for withdrawal in a preterm infant. ( Devlin, LA; Duncan, SD, 2013) |
"We report a 21-yr-old male patient with spondyloepiphyseal dysplasia tarda with progressive arthropathy who developed spastic paraplegia because of spinal stenosis caused by thoracic disk herniations." | 1.37 | Spondyloepiphyseal dysplasia tarda with progressive arthropathy complicated with paraplegia. ( Gelal, F; Memi, A; Olmez, N; Oz, B; Yoleri, O, 2011) |
"Baclofen per se has the potential of lowering blood pressure." | 1.35 | Intrathecal baclofen for autonomic instability due to spinal cord injury. ( Kofler, M; Poustka, K; Saltuari, L, 2009) |
"Ischemic paraplegia was induced in Sprague-Dawley rats by transient aortic occlusion (10 min) in combination with systemic hypotension (40 mm Hg)." | 1.33 | Measurement of peripheral muscle resistance in rats with chronic ischemia-induced paraplegia or morphine-induced rigidity using a semi-automated computer-controlled muscle resistance meter. ( Hefferan, MP; Kakinohana, O; Marsala, J; Marsala, M; Nakamura, S; Tomori, Z, 2005) |
"Baclofen inhibits spasticity by blocking excitatory neurotransmitters in the spinal dorsal horn." | 1.32 | Implantable baclofen pump as an adjuvant in treatment of pressure sores. ( Davison, S; Heckler, F; Kim, S; Mess, SA, 2003) |
"Two patients who had severe spinal spasticity with painful flexor spasms were treated with oral baclofen with relief of symptoms." | 1.28 | Pathophysiology and treatment of spasticity: report of two cases. ( Narayanaswamy, AS, 1992) |
" Even with a very small dosage of Baclofen patients who were previously treated until intoxication without success there was a favorable reduction in spasticity." | 1.28 | [Continuous intrathecal baclofen therapy using an implantable pump system in severe spasticity]. ( Behrens, C; Braunsdorf, WE; Kleiter, K; Kuhlendahl, HD; Volkheimer, A, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (18.87) | 18.7374 |
1990's | 13 (24.53) | 18.2507 |
2000's | 14 (26.42) | 29.6817 |
2010's | 13 (24.53) | 24.3611 |
2020's | 3 (5.66) | 2.80 |
Authors | Studies |
---|---|
Roth, J | 1 |
Agha, H | 1 |
Davis, C | 1 |
Filipetto, F | 1 |
Walden, J | 1 |
Trbovich, M | 1 |
Lugović-Mihić, L | 1 |
Duvančić, T | 1 |
Pavić, I | 1 |
Gverić-Grginić, A | 1 |
Šitum, M | 1 |
Dediol, I | 1 |
Gold, J | 1 |
Zhao, K | 1 |
Abraham, M | 1 |
Behmer Hansen, R | 1 |
Lad, M | 1 |
Mammis, A | 1 |
Mobolaji-Lawal, M | 1 |
Chaudhuri, R | 1 |
Marsh, RH | 1 |
Miller, ES | 1 |
Bhatia, K | 1 |
Ma, L | 1 |
Shi, Y | 1 |
Chen, Z | 1 |
Li, S | 1 |
Qin, W | 1 |
Zhang, J | 1 |
Duncan, SD | 1 |
Devlin, LA | 1 |
Bauman, WA | 2 |
La Fountaine, MF | 1 |
Cirnigliaro, CM | 2 |
Kirshblum, SC | 2 |
Spungen, AM | 2 |
Frémondière, F | 1 |
Saoût, V | 1 |
Lacœuille, F | 1 |
Ferrapie, AL | 1 |
Menei, P | 1 |
Couturier, O | 1 |
Richard, I | 1 |
Dinomais, M | 1 |
Taira, T | 1 |
Takeda, N | 1 |
Levy, J | 1 |
De Brier, G | 1 |
Hugeron, C | 1 |
Lansaman, T | 1 |
Bensmail, D | 1 |
Kofler, M | 2 |
Poustka, K | 1 |
Saltuari, L | 2 |
Ivano, D | 1 |
Giuseppe, M | 1 |
Angelo, F | 1 |
Yoleri, O | 1 |
Oz, B | 1 |
Olmez, N | 1 |
Memi, A | 1 |
Gelal, F | 1 |
Dones, I | 1 |
Broggi, G | 1 |
Bischoff, A | 1 |
Berger, B | 1 |
Vienenkoetter, B | 1 |
Korporal, M | 1 |
Rocco, A | 1 |
Meinck, HM | 1 |
Steiner, T | 1 |
Colachis, SC | 1 |
Rea, GL | 1 |
Roberts, AG | 1 |
Graves, CR | 1 |
Konrad, PE | 1 |
Groomes, TE | 1 |
Pfister, AA | 1 |
Damian, MM | 1 |
Charles, PD | 1 |
Mess, SA | 1 |
Kim, S | 1 |
Davison, S | 1 |
Heckler, F | 1 |
Pasquier, Y | 1 |
Cahana, A | 1 |
Schnider, A | 1 |
Vidal, J | 2 |
Gregori, P | 1 |
Guevara, D | 1 |
Portell, E | 1 |
Vallés, M | 1 |
Vaidyanathan, S | 1 |
Soni, BM | 1 |
Oo, T | 1 |
Hughes, PL | 1 |
Singh, G | 1 |
Mansour, P | 1 |
Marsala, M | 1 |
Hefferan, MP | 1 |
Kakinohana, O | 1 |
Nakamura, S | 1 |
Marsala, J | 1 |
Tomori, Z | 1 |
Morrison, NG | 1 |
Zhang, RL | 1 |
Cappell, MS | 1 |
Nguyen, T | 1 |
Katz, PO | 1 |
Barker, I | 1 |
Grant, IS | 1 |
Kirubakaran, V | 1 |
Mayfield, D | 1 |
Rengachary, S | 1 |
Kirkland, LR | 1 |
Eriksson, G | 1 |
Swahn, CG | 1 |
Albright, AL | 1 |
Barron, WB | 1 |
Fasick, MP | 1 |
Polinko, P | 1 |
Janosky, J | 1 |
Fakhoury, T | 1 |
Abou-Khalil, B | 1 |
Blumenkopf, B | 1 |
Southgate, HJ | 1 |
Masterson, R | 1 |
Rode, G | 1 |
Mertens, P | 1 |
Beneton, C | 1 |
Schmitt, M | 1 |
Boisson, D | 1 |
Ridgeway, B | 1 |
Wallace, M | 1 |
Gerayli, A | 1 |
Turner, MR | 1 |
Gainsborough, N | 1 |
Le Breton, F | 1 |
Daviet, JC | 1 |
Monteil, J | 1 |
Munoz, M | 1 |
Dudognon, P | 1 |
Salle, JY | 1 |
Ratnayaka, BD | 1 |
Dhaliwal, H | 1 |
Watkin, S | 1 |
Haubensak, K | 1 |
Jones, RF | 1 |
Lance, JW | 1 |
Hachen, HJ | 1 |
Krucker, V | 1 |
Narayanaswamy, AS | 1 |
Putty, TK | 1 |
Shapiro, SA | 1 |
Vanneste, J | 1 |
Augustijn, P | 1 |
Talalla, A | 1 |
Grundy, D | 1 |
Macdonell, R | 1 |
Braunsdorf, WE | 1 |
Kuhlendahl, HD | 1 |
Volkheimer, A | 1 |
Behrens, C | 1 |
Kleiter, K | 1 |
Latash, ML | 1 |
Penn, RD | 1 |
Corcos, DM | 1 |
Gottlieb, GL | 1 |
Müller, H | 1 |
Sarges, R | 1 |
Jouaux, J | 1 |
Runte, W | 1 |
Lampante, L | 1 |
Baumgartner, H | 1 |
Schmutzhard, E | 1 |
Russegger, L | 1 |
Aichner, F | 1 |
Gerstenbrand, F | 1 |
Meyerson, B | 1 |
Lind, G | 1 |
Linderoth, B | 1 |
Frost, F | 1 |
Nanninga, J | 1 |
Penn, R | 1 |
Savoy, S | 1 |
Wu, Y | 1 |
Azouvi, P | 1 |
Roby-Brami, A | 1 |
Tougeron, A | 1 |
Bussel, B | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized, Placebo Controlled Trial of Botulinum Toxin for Paratonic Rigidity in People With Advanced Cognitive Impairment[NCT02212119] | Phase 2 | 10 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 reviews available for baclofen and Paralysis, Legs
Article | Year |
---|---|
Encephalopathy of Unknown Origin in a Baclofen Patient: Case Report and Review of the Literature.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Baclofen; Brain Diseases; Electroencephalography; | 2020 |
[Intrathecal baclofen therapy for hereditary spastic paraplegia].
Topics: Adult; Aged; Baclofen; Catheters; Dose-Response Relationship, Drug; GABA-B Receptor Agonists; Humans | 2014 |
EEG changes in intrathecal baclofen overdose: a case report and review of the literature.
Topics: Aged; Baclofen; Electroencephalography; Humans; Injections, Spinal; Male; Multiple Sclerosis; Muscle | 1998 |
Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen.
Topics: Adult; Baclofen; Creatine Kinase; Electrocardiography; Humans; Male; Muscle Relaxants, Central; Musc | 2001 |
3 trials available for baclofen and Paralysis, Legs
Article | Year |
---|---|
Low-dose baclofen therapy raised plasma insulin-like growth factor-1 concentrations, but not into the normal range in a predictable and sustained manner in men with chronic spinal cord injury.
Topics: Adult; Baclofen; Chronic Disease; Dose-Response Relationship, Drug; Humans; Insulin-Like Growth Fact | 2013 |
Effect of low-dose baclofen administration on plasma insulin-like growth factor-I in persons with spinal cord injury.
Topics: Adult; Baclofen; Chronic Disease; Dose-Response Relationship, Drug; Humans; Insulin-Like Growth Fact | 2006 |
A double-blind trial with the antispasticity drug Lioresal in 15 paraplegics with upper neuron lesions.
Topics: Aminobutyrates; Baclofen; Clinical Trials as Topic; Double-Blind Method; Humans; Motor Neurons; Neur | 1977 |
46 other studies available for baclofen and Paralysis, Legs
Article | Year |
---|---|
Baclofen bridging, weaning protocol and pain management of a person with T6 paraplegia who required removal of intrathecal baclofen pump due to wound infection.
Topics: Baclofen; Humans; Infusion Pumps, Implantable; Injections, Spinal; Muscle Relaxants, Central; Muscle | 2021 |
Interaction between a smartphone and intrathecal baclofen pump case report.
Topics: Adult; Baclofen; Catheters; Humans; Male; Muscle Spasticity; Paraplegia; Smartphone; United States | 2023 |
Baclofen-Induced Dyshidrosiform Bullous Pemphigoid in a Paraplegic Patient Complicated by Methicillin-Resistant Staphylococcus aureus (MRSA) and Urinary Infection.
Topics: Baclofen; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Muscle Relaxants, | 2019 |
Generalized Itching and Lower-Extremity Spasticity in a Patient with Intrathecal Baclofen Pump.
Topics: Adult; Baclofen; Diagnosis, Differential; Humans; Infusions, Intravenous; Injections, Spinal; Lower | 2018 |
A novel KIAA0196 mutation in a Chinese patient with spastic paraplegia 8: A case report.
Topics: Asian People; Baclofen; Child; Electromyography; Humans; Male; Muscle Relaxants, Central; Neural Con | 2018 |
Use of baclofen for withdrawal in a preterm infant.
Topics: Adult; Baclofen; Cervical Vertebrae; Cesarean Section; Dose-Response Relationship, Drug; Female; Hum | 2013 |
Isotopic scintigraphy combined with computed tomography: a useful method for investigating inefficiency of intrathecal baclofen.
Topics: Baclofen; Female; Humans; Indium Radioisotopes; Infusion Pumps, Implantable; Middle Aged; Muscle Rel | 2014 |
Takotsubo cardiomyopathy as a reversible complication of intrathecal baclofen withdrawal.
Topics: Baclofen; Humans; Infusions, Spinal; Male; Middle Aged; Muscle Relaxants, Central; Paraplegia; Subst | 2016 |
Intrathecal baclofen for autonomic instability due to spinal cord injury.
Topics: Abdominal Wall; Antihypertensive Agents; Autonomic Dysreflexia; Baclofen; Benzimidazoles; Biphenyl C | 2009 |
"Careful" reprogramming of baclofen intrathecal programmable synchromed infusion pumps at their replacement in a series of 156 patients.
Topics: Baclofen; Humans; Infusion Pumps, Implantable; Muscle Relaxants, Central; Paraplegia; Software | 2011 |
Spondyloepiphyseal dysplasia tarda with progressive arthropathy complicated with paraplegia.
Topics: Analgesics; Arthralgia; Baclofen; Disease Progression; Follow-Up Studies; Humans; Low Back Pain; Mal | 2011 |
A case of very long-term appearing drug tolerance to intrathecal baclofen.
Topics: Aged; Baclofen; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Injections, Spinal; Male; | 2010 |
[From physical therapy to botulinum toxin: treatments in distressing spasticity].
Topics: Baclofen; Botulinum Toxins, Type A; Humans; Muscle Relaxants, Central; Muscle Spasticity; Paraplegia | 2011 |
Accidental intoxication with 60 mg intrathecal baclofen: survived.
Topics: Baclofen; Critical Care; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Middle Age | 2012 |
Monitoring of creatinine kinase during weaning of intrathecal baclofen and with symptoms of early withdrawal.
Topics: Adult; Baclofen; Creatine Kinase; Equipment Contamination; Humans; Infusion Pumps, Implantable; Inje | 2003 |
Intrathecal baclofen pump implantation during pregnancy.
Topics: Adult; Baclofen; Dose-Response Relationship, Drug; Female; Humans; Infusion Pumps, Implantable; Inje | 2003 |
Implantable baclofen pump as an adjuvant in treatment of pressure sores.
Topics: Adult; Baclofen; GABA Agonists; Humans; Infusion Pumps, Implantable; Injections, Spinal; Middle Aged | 2003 |
Subdural catheter migration may lead to baclofen pump dysfunction.
Topics: Accidental Falls; Adult; Baclofen; Catheterization; Equipment Failure; Follow-Up Studies; Foreign-Bo | 2003 |
Efficacy of intrathecal morphine in the treatment of baclofen tolerance in a patient on intrathecal baclofen therapy (ITB).
Topics: Adult; Baclofen; Drug Tolerance; Female; Humans; Injections, Spinal; Morphine; Paraplegia | 2004 |
Delayed complications of discontinuation of intrathecal baclofen therapy: resurgence of dyssynergic voiding, which triggered off autonomic dysreflexia and hydronephrosis.
Topics: Adolescent; Autonomic Dysreflexia; Baclofen; Humans; Hydronephrosis; Injections, Spinal; Male; Parap | 2004 |
Measurement of peripheral muscle resistance in rats with chronic ischemia-induced paraplegia or morphine-induced rigidity using a semi-automated computer-controlled muscle resistance meter.
Topics: Anesthetics, Inhalation; Animals; Baclofen; Chronic Disease; Electromyography; Halothane; Injections | 2005 |
Baclofen facilitates PEG placement in paraplegia-in-flexion syndrome.
Topics: Aged; Baclofen; Female; Follow-Up Studies; Gastrostomy; Humans; Muscle Contraction; Muscle Relaxants | 2006 |
Convulsions after abrupt withdrawal of baclofen.
Topics: Baclofen; Epilepsy, Tonic-Clonic; Female; Humans; Middle Aged; Paraplegia; Substance Withdrawal Synd | 1982 |
Dyskinesia and psychosis in a patient following baclofen withdrawal.
Topics: Adult; Baclofen; Humans; Male; Movement Disorders; Muscle Spasticity; Pain; Paraplegia; Psychoses, S | 1984 |
Baclofen dosage: a suggestion.
Topics: Baclofen; Humans; Male; Paraplegia; Spasm | 1984 |
Concentrations of baclofen in serum and breast milk from a lactating woman.
Topics: Adult; Baclofen; Female; Humans; Infant, Newborn; Lactation; Milk, Human; Paraplegia; Pregnancy; Pre | 1981 |
Continuous intrathecal baclofen infusion for spasticity of cerebral origin.
Topics: Adolescent; Adult; Baclofen; Cerebral Palsy; Child; Child, Preschool; Humans; Infusion Pumps, Implan | 1993 |
Lessons to be learned: a case study approach: prolonged methaemoglobinaemia due to inadvertent dapsone poisoning; treatment with methylene blue and exchange transfusion.
Topics: Adult; Antidotes; Baclofen; Dapsone; Exchange Transfusion, Whole Blood; Folic Acid Antagonists; Hemo | 1999 |
Regression of vasomotor disorders under intrathecal baclofen in a case of spastic paraplegia.
Topics: Adult; Baclofen; Disability Evaluation; Humans; Infusion Pumps, Implantable; Male; Motor Skills; Mus | 1999 |
[Current data on bipolar disorders, epilepsy and spasm. 4th Neuro-Forum, Dresden].
Topics: Baclofen; Benzodiazepines; Bipolar Disorder; Clonidine; Epilepsy; Humans; Muscle Relaxants, Central; | 1999 |
Ziconotide for the treatment of severe spasticity after spinal cord injury.
Topics: Adult; Analgesics, Opioid; Baclofen; Calcium Channel Blockers; Drug Resistance; Humans; Male; Morphi | 2000 |
Radioisotopic control for baclofen pump catheter failure.
Topics: Adult; Baclofen; Equipment Failure; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; M | 2001 |
Drug points: Neonatal convulsions after withdrawal of baclofen.
Topics: Baclofen; Female; GABA Agonists; Humans; Infant, Newborn; Maternal-Fetal Exchange; Muscle Relaxants, | 2001 |
Bacloffen (Lioresal) in the long-term management of spasticity.
Topics: Adolescent; Adult; Aged; Aminobutyrates; Baclofen; Cerebral Palsy; Child; Female; Humans; Long-Term | 1976 |
Clinical and laboratory assessment of the efficacy of baclofen (Lioresal) on urethral sphincter spasticity in patients with traumatic paraplegia.
Topics: Administration, Oral; Adolescent; Adult; Aminobutyrates; Baclofen; Drug Tolerance; Humans; Injection | 1977 |
Pathophysiology and treatment of spasticity: report of two cases.
Topics: Adult; Arachnoiditis; Baclofen; Diazepam; Female; Humans; Male; Muscle Spasticity; Paraplegia; Tuber | 1992 |
Efficacy of dorsal longitudinal myelotomy in treating spinal spasticity: a review of 20 cases.
Topics: Adult; Aged; Baclofen; Female; Humans; Injections, Spinal; Male; Middle Aged; Paraplegia; Quadripleg | 1991 |
Intrathecal baclofen for treatment of spasticity.
Topics: Adult; Aged; Baclofen; Dose-Response Relationship, Drug; Humans; Injections, Spinal; Male; Paraplegi | 1990 |
The effect of intrathecal baclofen on the lower urinary tract in paraplegia.
Topics: Baclofen; Humans; Injections, Spinal; Leg; Male; Muscle Tonus; Paraplegia; Penile Erection; Pressure | 1990 |
[Continuous intrathecal baclofen therapy using an implantable pump system in severe spasticity].
Topics: Baclofen; Dose-Response Relationship, Drug; Humans; Infusion Pumps, Implantable; Motor Neurons; Musc | 1990 |
Effects of intrathecal baclofen on voluntary motor control in spastic paresis.
Topics: Baclofen; Electromyography; Humans; Injections, Spinal; Motor Activity; Paraplegia; Volition | 1990 |
[Intraoperative suppression of spasticity using intrathecal baclofen].
Topics: Adult; Aged; Baclofen; Humans; Injections, Spinal; Intraoperative Period; Male; Muscle Spasticity; P | 1990 |
Failure of physostigmine in treatment of acute severe intrathecal baclofen intoxication.
Topics: Acute Disease; Adolescent; Baclofen; Humans; Injections, Spinal; Male; Paraplegia; Physostigmine | 1990 |
[Treatment of spasticity using an intrathecal infusion of baclofen].
Topics: Adult; Baclofen; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; Middle Aged; | 1989 |
Intrathecal baclofen infusion. Effect on bladder management programs in patients with myelopathy.
Topics: Adult; Baclofen; Female; Humans; Injections, Spinal; Male; Muscle Spasticity; Paraplegia; Urinary Bl | 1989 |
[Antispastic treatment of paraplegic patients].
Topics: Baclofen; Contracture; Dantrolene; Diazepam; Humans; Muscle Spasticity; Nursing Care; Paraplegia | 1988 |